CORONAVIRUS/Adimmune gets green light to start human trials of COVID-19 vaccine
08/20/2020 05:49 PM
Taipei, Aug. 20 (CNA) An experimental COVID-19 vaccine developed by Taiwanese maker Adimmune Corp. has been given the green light to start human trials, making it the first in the country to receive approval, Taiwan's Food and Drug Administration (FDA) said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![Slovakia to ship COVID vaccine donation to Taiwan; doses increased]()
Slovakia to ship COVID vaccine donation to Taiwan; doses increasedSlovakia will donate an extra 150,000 doses of the AstraZeneca COVID-19 vaccine to Taiwan, up from the original pledge of 10,000, and will deliver the donation in one shipment on ...09/24/2021 10:55 PM![Vaccine rollout just one factor in looking at lowering of COVID alert]()
Vaccine rollout just one factor in looking at lowering of COVID alertThe Central Epidemic Command Center (CECC) will ease COVID-19 restrictions depending on the vaccine rollout and other factors, but lowering the current Level 2 alert will require ...09/24/2021 05:56 PM![Taiwan reports 8 new COVID-19 cases, no deaths]()
Taiwan reports 8 new COVID-19 cases, no deathsTaiwan reported eight new COVID-19 cases, all but one of them contracted overseas, and no deaths from the disease on Friday, according to the Central Epidemic Command Center ...09/24/2021 02:51 PM
Latest
- Politics
Taiwan's 'democratic values' will be factor in CPTPP entry evaluation: U.S.
09/25/2021 01:01 PM - Society
Taiwan headline news
09/25/2021 11:56 AM - Politics
Voting gets underway for KMT chairman, party representative elections
09/25/2021 08:37 AM - Society
Taiwan court rules to allow trans woman's ID card gender change request
09/24/2021 11:37 PM - Society
Taiwan's police increase patrols after bomb threats to high-speed rail
09/24/2021 11:00 PM
